Boston Scientific Offers WALLSTENT for Carotid Stenting


October 27, 2008

Boston Scientific's Carotid WALLSTENT Endoprosthesis is designed for the treatment of patients with carotid artery disease who are at high risk for surgery.

The WALLSTENT is a self-expanding stent mounted on a rapid exchange delivery system, features a closed-cell design, engineered for excellent lesion coverage and angiographic results. The system is designed to be highly deliverable and provide access to the toughest lesions, the company said.

The device was FDA approved in Octoiber 2008.